Price movement over the last 24 hours
Avalon Labs vs Symbiosis — how do they compare? Avalon Labs trades at Rp398.99 (market cap Rp67,06M, Rp97,95M 24h volume), while Symbiosis trades at Rp293.08 (market cap Rp34,08M, Rp2,71M 24h volume). The key difference: Avalon Labs is the larger of the two by market cap, and Avalon Labs's circulating supply is 161,7M / 1B AVL (17%) versus 97M / 99,5M SIS (98%) for Symbiosis. Which is the better fit depends on your goals — on Pluang, investors hold Avalon Labs for 8 Days and Symbiosis for 11 Days on average.
| AVL | SIS | |
|---|---|---|
Market Cap | Rp67,06M | Rp34,08M |
Volume (24h) | Rp97,95M | Rp2,71M |
Circulating Supply | 161,7M / 1B AVL (17%) | 97M / 99,5M SIS (98%) |
Typical Hold Time | 8 Days | 11 Days |
Signals from Pluang's Aura AI — not financial advice
AVL trades at Rp392.75 with a bearish technical signal, showing selling pressure in moving averages but neutral oscillators. The token hovers near support at Rp393, with resistance at Rp409. Market cap is Rp66.43M with 17% of max supply circulating. Recent news lacks crypto-specific updates, focusing incorrectly on corporate activities.
Outlook remains cautious due to weak technicals and low liquidity. Key risks include high volatility and limited adoption. Opportunities exist if the project gains ecosystem traction, but current fundamentals show no significant developments for token holders.
Symbiosis (SIS) shows limited market activity with a modest market cap of Rp34.08M and near-full circulating supply of 98%. The token exhibits short holding periods averaging 11 days, suggesting speculative trading patterns. No recent protocol updates or significant ecosystem developments were identified, indicating stagnant network growth.
Overall outlook remains cautious due to low liquidity and limited adoption. Key opportunity lies in potential protocol revival, while major risks include extreme volatility and regulatory uncertainty common to low-cap cryptocurrencies.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Avalon Labs is building an on-chain financial center for Bitcoin, offering solutions like BTC-backed lending, a Bitcoin-backed stablecoin, yield-generating accounts, and a credit card. Our goal is to create a scalable, transparent, and accessible financial network for Bitcoin holders to use Bitcoin as an economic asset. AVL is the governance token of the Avalon Labs ecosystem. We started as the world's largest issuer of Bitcoin-backed collateralized debt positions (CDPs) and have since expanded into DeFi lending, fixed-rate CeDeFi models, and stablecoins. This growth, driven by community demand, positions Avalon as a leader in on-chain finance. With AVL, we empower our community to actively shape the future of Avalon.
Read more on AVL →Symbiosis is a platform for cross-chain swaps that eliminates the need for multiple transactions. It aggregates liquidity from various Automated Market Makers (AMMs) and Decentralized Exchanges (DEXs) across EVM and non-EVM chains. The platform uses a decentralized Relayers Network, consisting of relayer nodes that verify and transfer information across blockchains. This network ensures secure data transfer and enhances security against central points of failure. Relayer nodes must stake SIS tokens to participate in the consensus and process swaps.
Read more on SIS →